November 9-11, 2020 | Virtual Conference


Judith Zander, M.D.

Office of Pharmacovigilance and Epidemiology, OSE, CDER, FDA

Judith (Judy) Zander M.D. is the Director of the Office of Pharmacovigilance and Epidemiology (OPE), in the Office of Surveillance and Epidemiology (OSE), in the Center for Drug Evaluation (CDER) at the U.S. Food and Drug Administration (FDA).She oversees the Divisions of Pharmacovigilance 1 and 2 and the Divisions of Epidemiology 1 and 2. Judy joined FDA in January 2017. She has more than 20 years of pharmaceutical industry in leadership roles in drug safety and risk management.

Skip to content